PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration
- PMID: 39177130
- DOI: 10.2174/0115680096307100240801095132
PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration
Abstract
Background: Results from the TCGA database showed that phosphatidylinositolspecific phospholipase Cγ2 (PLCG2) expression level in Lung Adenocarcinoma (LUAD) was notably decreased compared to adjacent tissues, so we unveiled its role of LUAD.
Objective: This study aims to explore the expression and clinical significance of Phosphatidylinositol- specific phospholipase Cγ2 (PLCG2) in lung adenocarcinoma (LUAD) cells and its role in cell proliferation and metastasis.
Methods: Differential PLCG2 mRNA and protein levels between LUAD tissues and adjacent tissues were analyzed from the TCGA database, TIMER, and UALCAN database. Differentially expressed genes were screened for patients in the high and low PLCG2 mRNA expression groups by the R package as well as GSEA. The expression level of PLCG2 in LUAD cells was detected using qRT-PCR and CCK8, clone formation, Transwell, and Western blot assays.
Results: PLCG2 was lowly expressed in LUAD and did not significantly correlate with the prognosis of LUAD. PLCG2 expression levels varied significantly in terms of patients' gender, age, T, N, and pathological stage. GO/KEGG enrichment analysis showed that co-expression of PLCG2 was mainly associated with the immune response- regulating cell-surface receptors, and so on. GSEA analysis showed enrichment pathways of PLCG2-related differential gees were primarily associated with the olfactory transduction pathway, ribosome, etc. R software analysis revealed a significant correlation between PLCG2 expression and six types of immune-infiltrating cells, positively correlated with immune checkpoint-related genes and negatively regulated by tumor mutational load. Overexpressing PLCG2 showed reduced LUAD cell proliferation, clone formation, cell migration and invasion, and epithelial-mesenchymal transition-associated proteins, compared with the control group.
Conclusion: PLCG2 is lowly expressed in LUAD tissues and is involved in immune infiltration of LUAD, inhibiting LUAD cell proliferation and metastasis.
Keywords: Lung adenocarcinoma; PLCG2; immune infiltration; lung cancer.; metastasis; migration; proliferation; tumor-infiltration immune cells.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.Int Immunopharmacol. 2024 Sep 10;138:112553. doi: 10.1016/j.intimp.2024.112553. Epub 2024 Jun 28. Int Immunopharmacol. 2024. PMID: 38943975
-
FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.Life Sci. 2021 Mar 1;268:119022. doi: 10.1016/j.lfs.2021.119022. Epub 2021 Jan 9. Life Sci. 2021. PMID: 33434533
-
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.Front Immunol. 2021 Jul 16;12:724741. doi: 10.3389/fimmu.2021.724741. eCollection 2021. Front Immunol. 2021. PMID: 34335635 Free PMC article.
-
DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma.Sci Rep. 2025 Jan 2;15(1):403. doi: 10.1038/s41598-024-84539-1. Sci Rep. 2025. PMID: 39747313 Free PMC article.
-
Transmembrane mucins in lung adenocarcinoma: understanding of current molecular mechanisms and clinical applications.Cell Death Discov. 2025 Apr 10;11(1):163. doi: 10.1038/s41420-025-02455-3. Cell Death Discov. 2025. PMID: 40210618 Free PMC article. Review.
Cited by
-
Runs of homozygosity and selection signals analysis reveals domestication traits and divergence in local domestic duck breeds.Poult Sci. 2025 Jun 6;104(9):105404. doi: 10.1016/j.psj.2025.105404. Online ahead of print. Poult Sci. 2025. PMID: 40513394 Free PMC article.
References
MeSH terms
Substances
Grants and funding
- 2023KY902/Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
- JBZX-202003/Zhejiang Provincial Research Center for Cancer Intelligent Diagnosis and Molecular Technology
- 2022E10022/Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
LinkOut - more resources
Full Text Sources
Medical